Navigation Links
CPAP Therapy Most Effective for Sleep Apnea, Experts Say
Date:8/8/2011

MONDAY, Aug. 8 (HealthDay News) -- The most effective treatment for the nighttime breathing disorder known as obstructive sleep apnea is the continuous positive airway pressure (CPAP) machine, according to a new report.

A CPAP machine pumps air through a mask while the patient sleeps. This treatment is highly effective in improving sleep and reducing symptoms of obstructive sleep apnea, according to the review of available evidence.

However, side effects such as dry nose and mouth, nosebleeds, chest discomfort and feeling trapped can cause patients to abandon CPAP treatment, noted the authors of the report, which was funded by the U.S. Agency for Healthcare Research and Quality (AHRQ).

One expert called the report's findings "valuable."

"CPAP is known to be the most effective way to treat sleep apnea, but compliance is a big issue," said Dr. Linda Dahl, an Ear, Nose & Throat specialist at Lenox Hill Hospital in New York City. "It can be uncomfortable and difficult to use. Also, younger patients do not want the stigma of using it. Oral appliances are very helpful for certain types of sleep apnea, but they can be costly and are usually not covered by insurance."

Dahl, who was not involved in the new report, added that "there are also surgical treatments available. They are often not curative, but they do play a role in sleep apnea treatment. For example, if a patient has nasal obstruction and cannot tolerate CPAP, nasal surgery can open the nose so they can tolerate the CPAP mask.

The report also found that one other treatment -- a mouthpiece called a mandibular advancement device -- can be highly effective for sleep apnea patients. The device moves the jaw forward and keeps the airway open.

This treatment is often used if patients can't tolerate the CPAP machine, but potential side effects of the mandibular advancement device include loose or damaged teeth, the report noted.

While weight loss and surgery to clear airway blockage may also effectively treat sleep apnea, the evidence behind these treatments isn't as strong, according to the team from the Tufts Medical Center Evidence-Based Practice Center, which prepared the report.

"The bottom line is that every patient is an individual," Dahl said. "So it is important to know all of the possible treatment options when deciding what will work best. Unfortunately, sleep apnea is mutifactorial, so there is no magic treatment."

The new report, along with companion guides for consumers and medical professionals that summarize the latest evidence for treating obstructive sleep apnea, are available on the AHRQ website.

About 12 million Americans are known to have obstructive sleep apnea, and it's likely that millions more are undiagnosed, according to the AHRQ. The condition, caused by the repeated collapse and blockage of the upper airway during sleep, stops breathing many times through the night.

Obstructive sleep apnea can lead to high blood pressure, heart disease, diabetes and increased risk of accidents because of daytime fatigue.

"Obstructive sleep apnea is a frustrating and debilitating condition for so many Americans, and millions of people don't even know they have it. The resultant poor sleep and daytime sleepiness can lead to work-related or driving accidents," AHRQ director Dr. Carolyn M. Clancy said in an agency news release. "These guides and this new report will help patients and their doctors understand what treatment options might be best for them."

More information

The U.S. National Heart, Lung, and Blood Institute has more about sleep apnea treatments.

-- Robert Preidt

SOURCES: Linda Dahl, M.D., Ear, Nose & Throat specialist, Lenox Hill Hospital, New York City; U.S. Agency for Healthcare Research and Quality, news release, Aug. 8, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nicotine replacement therapy is over-promoted since most ex-smokers quit unassisted
2. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
3. Longview Therapy Center, PLLC, Unveils Its Definition Of Hope
4. Short-term radiation therapy successful on breast cancer
5. ASCROs Response to NY Times Articles on Radiation Therapy Incidents
6. Children With Cerebral Palsy Benefitting From New Physical Therapy Regimen
7. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
8. Behavioral therapy improves sleep and lives of patients with pain
9. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
10. Promising therapy for relapsing multibple sclerosis
11. Split-course palliative radiotherapy confirmed as effective treatment for advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CPAP Therapy Most Effective for Sleep Apnea, Experts Say
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams & ... This competition was hosted jointly by HSN and Good Housekeeping. , Steven ...
(Date:3/23/2017)... VA (PRWEB) , ... March ... ... Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. ... 3:00 p.m. ET, http://www.fdanews.com/mdclineval                  , How will the new EU ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions unveils the ... 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... chart types with a comprehensive set of features including built-in workflow, interactive audit ...
(Date:3/23/2017)... ... ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous power ... Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures which ... new book presents actual events in the life of her family, which validate her ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: the true-life ... infinitely more profound faith of God’s promise of Heaven for His people. “My Journey ... each day with his wife, three children and six grandchildren living and doing for ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
(Date:3/23/2017)... 2017 The Board of Directors of NeuroVive ... Meeting, which is to take place on Thursday, April 27, 2017, ... Lund, Sweden . ... Please see the attached notification, which is being announced within ... NeuroVive Pharmaceutical AB (Publ) The Board Of Directors About ...
Breaking Medicine Technology: